Latest Product Release: Repackaged Bevacizumab in the SJJ Small Volume Syringe

PORTAL REGISTRATION AND SUPPORT

Portal Login

Newsroom

Discover the most recent innovations and updates from Pine Pharmaceuticals.

Manufacturing Award 2023 | Buffalo Business First | Pine Pharmaceuticals

News

May 24, 2023

Business First Recognizes Pine Pharmaceuticals During 2023 Manufacturing Awards

We are pleased to announce that Buffalo Business First has named Pine Pharmaceuticals a 2023…

Pine Pharmaceuticals

Love0

Company Update

May 3, 2023

Pine Pharmaceuticals Assumes Athenex’s 503B Business, Preserving over 50 Jobs, Expanding its Product Offerings, and Serving Hospitals and Health Systems Nationwide

Tonawanda, NY, May 3, 2023 /PRNewswire/– Pine Pharmaceuticals, one of the nation’s largest and most…

Pine Pharmaceuticals

Love0

Upcoming Events

January 31, 2023

2023 Conferences and Trade Shows

ASRS Business of Retina March 17 – 19, 2023 Dallas, TX ASCA Annual Conference May…

Pine Pharmaceuticals

Love0

News

December 2, 2022

Pine Owners Recognized as One of the Top Family Businesses of 2022

Buffalo Business First has named Pine Pharmaceuticals a 2022 Family Business Award winner. This recognition…

Pine Pharmaceuticals

Love0

Company Update

September 21, 2022

Pine Announces Expansion Completion, Tripling Facility Size and Doubling Workforce

After the announcement of our expansion in December 2021, Pine Pharmaceuticals is pleased to share…

Pine Pharmaceuticals

Love0

News

July 22, 2022

Owners Al Sr. and Alfonse J. Muto Recognized for Second Consecutive Year as Fast 46 finalists

After being recognized in 2021, we are excited to share that Pine Pharmaceuticals’ owners Al…

Pine Pharmaceuticals

Love0

Thought Leadership

January 28, 2022

Three Easy Ways Pine Can Help Support Your Practice in the New Year

Are you looking to improve your practice in 2022? Pine is here to support you!…

Pine Pharmaceuticals

Love0

News

November 2, 2021

University at Buffalo Recognizes Owners Al Sr. and Alfonse J. Muto

The University at Buffalo recently recognized Pine Pharmaceuticals owners Al Sr. and Alfonse J. Muto…

Pine Pharmaceuticals

Love0

Product Update

February 11, 2021

Cyclopentolate is on the FDA’s Drug Shortage List – Combination Drops Still Available

Despite the recent inclusion of Cyclopentolate on the FDA’s Drug Shortage List, Pine Pharmaceuticals has combination…

Pine Pharmaceuticals

Love0

Company Update

January 26, 2021

Pine Pharmaceuticals Announces Massive New Expansion, Tripling Footprint

Pine Pharmaceuticals is pleased to announce the expansion of our 503B outsourcing facility located at…

Pine Pharmaceuticals

Love0

PORTAL REGISTRATION AND SUPPORT

Portal Login

Newsroom

Business First Recognizes Pine Pharmaceuticals During 2023 Manufacturing Awards

Pine Pharmaceuticals Assumes Athenex’s 503B Business, Preserving over 50 Jobs, Expanding its Product Offerings, and Serving Hospitals and Health Systems Nationwide

2023 Conferences and Trade Shows

Pine Owners Recognized as One of the Top Family Businesses of 2022

Pine Announces Expansion Completion, Tripling Facility Size and Doubling Workforce

Owners Al Sr. and Alfonse J. Muto Recognized for Second Consecutive Year as Fast 46 finalists

Three Easy Ways Pine Can Help Support Your Practice in the New Year

University at Buffalo Recognizes Owners Al Sr. and Alfonse J. Muto

Cyclopentolate is on the FDA’s Drug Shortage List – Combination Drops Still Available

Pine Pharmaceuticals Announces Massive New Expansion, Tripling Footprint

Our dedicated Customer Support team is here to help.

What We Prepare

Who We Serve

About Pine

Contact Us

cGMP-Compliant 503B Outsourcing Facility